Last reviewed · How we verify
Local anesthetic injection of CPL-01
Local anesthetic injection of CPL-01 is a Local anesthetic Small molecule drug developed by Cali Pharmaceuticals LLC. It is currently in Phase 3 development for Local anesthesia for injection (specific indication not publicly detailed). Also known as: CPL-01, Long-acting ropivacaine.
CPL-01 is a local anesthetic injection that blocks nerve conduction to provide localized pain relief and anesthesia at the injection site.
CPL-01 is a local anesthetic injection that blocks nerve conduction to provide localized pain relief and anesthesia at the injection site. Used for Local anesthesia for injection (specific indication not publicly detailed).
At a glance
| Generic name | Local anesthetic injection of CPL-01 |
|---|---|
| Also known as | CPL-01, Long-acting ropivacaine |
| Sponsor | Cali Pharmaceuticals LLC |
| Drug class | Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Anesthesia |
| Phase | Phase 3 |
Mechanism of action
As a local anesthetic, CPL-01 works by inhibiting sodium channel activity in nerve fibers, preventing the generation and propagation of action potentials in sensory and motor neurons. This results in reversible loss of sensation and motor function in the localized area of administration. The drug is designed for direct injection into tissues requiring anesthesia.
Approved indications
- Local anesthesia for injection (specific indication not publicly detailed)
Common side effects
- Local injection site reactions
- Systemic toxicity (if absorbed)
Key clinical trials
- CPL-01 in the Management of Postoperative Pain After Bunionectomy (PHASE3)
- Herniorrhaphy for Postoperative Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Local anesthetic injection of CPL-01 CI brief — competitive landscape report
- Local anesthetic injection of CPL-01 updates RSS · CI watch RSS
- Cali Pharmaceuticals LLC portfolio CI
Frequently asked questions about Local anesthetic injection of CPL-01
What is Local anesthetic injection of CPL-01?
How does Local anesthetic injection of CPL-01 work?
What is Local anesthetic injection of CPL-01 used for?
Who makes Local anesthetic injection of CPL-01?
Is Local anesthetic injection of CPL-01 also known as anything else?
What drug class is Local anesthetic injection of CPL-01 in?
What development phase is Local anesthetic injection of CPL-01 in?
What are the side effects of Local anesthetic injection of CPL-01?
Related
- Drug class: All Local anesthetic drugs
- Manufacturer: Cali Pharmaceuticals LLC — full pipeline
- Therapeutic area: All drugs in Pain Management / Anesthesia
- Indication: Drugs for Local anesthesia for injection (specific indication not publicly detailed)
- Also known as: CPL-01, Long-acting ropivacaine
- Compare: Local anesthetic injection of CPL-01 vs similar drugs
- Pricing: Local anesthetic injection of CPL-01 cost, discount & access